Effect of rifampicin & isoniazid on the steady state pharmacokinetics of moxifloxacin

Effect of rifampicin & isoniazid on the steady state pharmacokinetics of moxifloxacin

Bibliographic Details
Main Authors:	Ramachandran, Geetha, Kumar, A.K. Hemanth, Srinivasan, R., Geetharani, A., Sugirda, P., Nandhakumar, B., Nandini, R., Tharani, C. B.
Format:	Online
Language:	English
Published:	Medknow Publications & Media Pvt Ltd 2012
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3612327/

Similar Items

Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children
by: Mukherjee, Aparna, et al.
Published: (2015)

Fatal poisoning by isoniazid and rifampicin
by: Sridhar, A., et al.
Published: (2012)

Isoniazid- and rifampicin-induced thrombocytopenia
by: Yakar, Fatih, et al.
Published: (2013)

Naïve-pooled pharmacokinetic analysis of pyrazinamide, isoniazid and rifampicin in plasma and cerebrospinal fluid of Vietnamese children with tuberculous meningitis
by: Pouplin, Thomas, et al.
Published: (2016)

Lack of association between plasma levels of non-nucleoside reverse transcriptase inhibitors & virological outcomes during rifampicin co-administration in HIV-infected TB patients
by: Ramachandran, Geetha, et al.
Published: (2013)

Effectiveness of ellagic acid on isoniazid-rifampicin induced liver damage in rats
by: Ambrose, Samuel Stephen, et al.
Published: (2013)

Human PXR modulates hepatotoxicity associated with rifampicin and isoniazid co–therapy
by: Li, Feng, et al.
Published: (2013)

Protective Effects of Metallothionein on Isoniazid and Rifampicin-Induced Hepatotoxicity in Mice
by: Lian, Yong, et al.
Published: (2013)

Naringenin protects against isoniazid- and rifampicin-induced apoptosis in hepatic injury
by: Wang, Chao, et al.
Published: (2016)

Hepatoprotective Activity of Heptoplus on Isoniazid and Rifampicin Induced Liver Damage in Rats
by: Sankar, M., et al.
Published: (2015)

Low isoniazid and rifampicin concentrations in TB/HIV co-infected patients in Uganda
by: Sekaggya Wiltshire, Christine, et al.
Published: (2014)

Isoniazid, Pyrazinamide and Rifampicin Content Variation in Split Fixed-Dose Combination Tablets
by: Pouplin, Thomas, et al.
Published: (2014)

Effect of Rifampicin on the Pharmacokinetics of Lenvatinib in Healthy Adults
by: Shumaker, Robert C., et al.
Published: (2014)

High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial
by: Boeree, Martin J, et al.
Published: (2017)

Prevalence, Risk Factors, and Treatment Outcomes of Isoniazid- and Rifampicin- Mono-Resistant Pulmonary Tuberculosis in Lima, Peru
by: Villegas, Leonela, et al.
Published: (2016)

Agranulocytosis induced by anti-tubercular drugs, Isoniazid (INH) and Rifampicin (R) A rare case report
by: Basavaraj C. Bidarimath, et al.
Published: (2016-02-01)

Rapid Detection of Rifampicin- and Isoniazid-Resistant Mycobacterium tuberculosis using TaqMan Allelic Discrimination
by: Darban-Sarokhalil, Davood, et al.
Published: (2016)

Effects of Dosage, Comorbidities, and Food on Isoniazid Pharmacokinetics in Peruvian Tuberculosis Patients
by: Requena-Méndez, Ana, et al.
Published: (2014)

Pre-Existing Isoniazid Resistance, but Not the Genotype of Mycobacterium Tuberculosis Drives Rifampicin Resistance Codon Preference in Vitro
by: Bergval, Indra, et al.
Published: (2012)

Analysis of gene mutations associated with isoniazid, rifampicin and ethambutol resistance among Mycobacterium tuberculosis isolates from Ethiopia
by: Tessema, Belay, et al.
Published: (2012)

Rifampicin/Cotrimoxazole/Isoniazid Versus Mefloquine or Quinine + Sulfadoxine- Pyrimethamine for Malaria: A Randomized Trial
by: Genton, Blaise, et al.
Published: (2006)

Damage of testicular cell macromolecules and reproductive capacity of male rats following co-administration of ethambutol, rifampicin, isoniazid and pyrazinamide
by: Shayakhmetova, Ganna Mykhailivna, et al.
Published: (2012)

High Isoniazid Resistance Rates in Rifampicin Susceptible Mycobacterium tuberculosis Pulmonary Isolates from Pakistan
by: Fasih, Naima, et al.
Published: (2012)

Evaluation of Biochip System in Determining Isoniazid and Rifampicin Resistances of Mycobacterium Tuberculosis in Sputum Samples
by: Lu, Wei, et al.
Published: (2012)

Blood Agar Validation for Susceptibility Testing of Isoniazid, Rifampicin, Ethambutol, and Streptomycin to Mycobacterium tuberculosis Isolates
by: Coban, Ahmet Yilmaz
Published: (2013)

A new rapid colourimetric method for testing Mycobacterium tuberculosis susceptibility to isoniazid and rifampicin: a crystal violet decolourisation assay
by: Coban, Ahmet Yilmaz
Published: (2014)

Do We Need to Detect Isoniazid Resistance in Addition to Rifampicin Resistance in Diagnostic Tests for Tuberculosis?
by: Denkinger, Claudia M., et al.
Published: (2014)

Hepatoprotective activity of Ficus religiosa leaves against isoniazid+rifampicin and paracetamol induced hepatotoxicity
by: Parameswari, Sundaramoorthi Angala, et al.
Published: (2013)

Optimisation and validation of hplc method for simultaneous quantification of rifampicin, isoniazid, pyrazinamide, and ethambutol hydrochloride in anti-tuberculosis 4-FDC
by: Azhanie Sardangi
Published: (2015)

Evaluation of Direct Colorimetric MTT Assay for Rapid Detection of Rifampicin and Isoniazid Resistance in Mycobacterium tuberculosis
by: Hundie, Gadissa Bedada, et al.
Published: (2016)

Rapid Detection of Rifampicin and Isoniazid Resistant Mycobacterium tuberculosis Using Genotype MTBDRplus Assay in Nepal
by: Sharma, Bijay Kumar, et al.
Published: (2014)

Multicenter evaluation of crystal violet decolorization assay (CVDA) for rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis
by: Coban, Ahmet Yilmaz, et al.
Published: (2016)

Rapid Detection of Rifampicin- and Isoniazid-Resistant Mycobacterium tuberculosis Using Real-Time PCR
by: Sahebi, Leyla, et al.
Published: (2016)

Systems Pharmacology Approach Toward the Design of Inhaled Formulations of Rifampicin and Isoniazid for Treatment of Tuberculosis
by: Cilfone, NA, et al.
Published: (2015)

The clinical outcomes of oldest old patients with tuberculosis treated by regimens containing rifampicin, isoniazid, and pyrazinamide
by: Lin, Huang-Shen, et al.
Published: (2016)

Mycobacterium tuberculosis Uganda II is more susceptible to rifampicin and isoniazid compared to Beijing and Delhi/CAS families
by: Kasule, George W., et al.
Published: (2016)

Isoniazid Psychosis
by: U N Pathak, et al.
Published: (2003-01-01)

Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Newly Diagnosed Pulmonary TB Patients in Tanzania
by: Denti, Paolo, et al.
Published: (2015)

Pharmacokinetic Drug Interactions with Vandetanib during Coadministration with Rifampicin or Itraconazole
by: Martin, Paul, et al.
Published: (2012)

The impact of co-administration of ketoconazole and rifampicin on the pharmacokinetics of apremilast in healthy volunteers
by: Liu, Yong, et al.
Published: (2014)